» Articles » PMID: 22617878

RNA Mediated Toll-like Receptor Stimulation in Health and Disease

Overview
Journal RNA Biol
Specialty Molecular Biology
Date 2012 May 24
PMID 22617878
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Besides their well known functions in storage and translation of information nucleic acids have emerged as a target of pattern recognition receptors that drive activation of innate immunity. Due to the paucity of building block monomers used in nucleic acids, discrimination of host and microbial nucleic acids as a means of self/foreign discrimination is a complicated task. Pattern recognition receptors rely on discrimination by sequence, structural features and spatial compartmentalization to differentiate microbial derived nucleic acids from host ones. Microbial nucleic acid detection is important for the sensing of infectious danger and initiating an immune response to microbial attack. Failures in the underlying recognitions systems can have severe consequences: thus, inefficient recognition of microbial nucleic acids may increase susceptibility to infectious diseases. On the other hand, excessive immune responses as a result of failed self/foreign discrimination are associated with autoimmune diseases. This review gives a general overview over the underlying concepts of nucleic acid sensing by Toll-like receptors. Within this general framework, we focus on bacterial RNA and synthetic RNA oligomers.

Citing Articles

Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid-Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy.

Lopez-Cerda S, Molinaro G, Pareja Tello R, Correia A, Kunig S, Steinberger P ACS Appl Mater Interfaces. 2024; 16(15):18643-18657.

PMID: 38564504 PMC: 11040533. DOI: 10.1021/acsami.4c02363.


Review of Advances in Coating and Functionalization of Gold Nanoparticles: From Theory to Biomedical Application.

Arcos Rosero W, Bueno Barbezan A, de Souza C, Rostelato M Pharmaceutics. 2024; 16(2).

PMID: 38399309 PMC: 10892584. DOI: 10.3390/pharmaceutics16020255.


Nanoparticles and Antiviral Vaccines.

Liu S, Hu M, Liu X, Liu X, Chen T, Zhu Y Vaccines (Basel). 2024; 12(1).

PMID: 38250843 PMC: 10819235. DOI: 10.3390/vaccines12010030.


miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.

Huang W, Paul D, Calin G, Bayraktar R Cells. 2024; 13(1).

PMID: 38201290 PMC: 10778542. DOI: 10.3390/cells13010084.


Association of Toll-Like Receptor 7 (TLR7) Polymorphisms with Predisposition to Systemic Lupus Erythematosus (SLE): A Meta and Trial Sequential Analysis.

Ranjan S, Panda A Biochem Genet. 2023; 62(5):3350-3366.

PMID: 38103124 DOI: 10.1007/s10528-023-10600-9.


References
1.
Barton G, Kagan J, Medzhitov R . Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2005; 7(1):49-56. DOI: 10.1038/ni1280. View

2.
Baumann C, Aspalter I, Sharif O, Pichlmair A, Bluml S, Grebien F . CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010; 207(12):2689-701. PMC: 2989773. DOI: 10.1084/jem.20101111. View

3.
Lan T, Dai M, Wang D, Zhu F, Kandimalla E, Agrawal S . Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies. J Med Chem. 2009; 52(21):6871-9. DOI: 10.1021/jm901145s. View

4.
Kariko K, Buckstein M, Ni H, Weissman D . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005; 23(2):165-75. DOI: 10.1016/j.immuni.2005.06.008. View

5.
Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y, Homey B . Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449(7162):564-9. DOI: 10.1038/nature06116. View